Ellis Investment Partners LLC Has $1.35 Million Holdings in Procter & Gamble Company (The) $PG

Ellis Investment Partners LLC cut its position in Procter & Gamble Company (The) (NYSE:PG) by 2.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,449 shares of the company’s stock after selling 197 shares during the quarter. Ellis Investment Partners LLC’s holdings in Procter & Gamble were worth $1,346,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Benjamin Edwards Inc. grew its stake in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after buying an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC grew its stake in Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after buying an additional 4,562 shares during the last quarter. World Investment Advisors grew its stake in Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock valued at $8,677,000 after buying an additional 2,886 shares during the last quarter. Concurrent Investment Advisors LLC grew its stake in Procter & Gamble by 26.4% in the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after buying an additional 25,059 shares during the last quarter. Finally, Diversify Wealth Management LLC boosted its holdings in Procter & Gamble by 10.3% in the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company’s stock valued at $3,849,000 after purchasing an additional 2,210 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at $50,228,106.25. This trade represents a 11.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at $8,279,007.34. This represents a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock worth $23,421,279 over the last ninety days. Corporate insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. BNP Paribas Exane decreased their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Barclays decreased their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Bank of America decreased their price target on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Berenberg Bank raised their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Finally, Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $172.21.

Procter & Gamble Price Performance

NYSE:PG opened at $149.69 on Monday. The company has a 50-day moving average of $155.24 and a 200-day moving average of $159.41. The company has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $149.45 and a 52 week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the firm earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.